SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-98-002925
Filing Date
1998-06-16
Accepted
1998-06-16 00:00:00
Documents
11
Period of Report
1998-06-12
Items
Item 5: Other events
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 6504
2 RESTATED FINANCIAL DATA SCHEDULE EX-27.01 2445
3 RESTATED FINANCIAL DATA SCHEDULE EX-27.02 2286
4 RESTATED FINANCIAL DATA SCHEDULE EX-27.03 2287
5 RESTATED FINANCIAL DATA SCHEDULE EX-27.04 2290
6 RESTATED FINANCIAL DATA SCHEDULE EX-27.05 2446
7 RESTATED FINANCIAL DATA SCHEDULE EX-27.06 2286
8 RESTATED FINANCIAL DATA SCHEDULE EX-27.07 2289
9 RESTATED FINANCIAL DATA SCHEDULE EX-27.08 2290
10 RESTATED FINANCIAL DATA SCHEDULE EX-27.09 2445
11 SELECTED FINANCIAL DOCUMENTS EX-99.1 152719
  Complete submission text file 0000891618-98-002925.txt   182869
Mailing Address 3174 PORTER DRIVE 3174 PORTER DRIVE PALO ALTO CA 94304
Business Address 3174 PORTER DR PALO ALTO CA 94304 6508550555
INCYTE PHARMACEUTICALS INC (Filer) CIK: 0000879169 (see all company filings)

IRS No.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12400 | Film No.: 98649326
SIC: 8731 Services-Commercial Physical & Biological Research